• About
  • About CANNT
  • Major Activities
  • Board of Directors and Contacts
  • Current Bylaws
  • Why should I become a member?
    • Fact Sheet on Representation
    • Fact Sheet on Liaisons
  • Join CANNT
• CANNT Journal
  • CANNT Journal
    • 2010
    • 2009
    • 2008
    • 2007
    • 2006
    • 2005
    • 2003
    • 2002
    • 2004
    • 2001
    • 2000
  • Download Journals
  • Information for Advertisers
  • Guidelines For Authors
  • Library/Institutional Rates
• Standards of Practice
  • Standards of Nursing Practice
  • Standards of Technical Practice
• Events
  • Calendar
  • CANNT / ACITN 2010
• Education
  • Certification
  • CNeph(C) Prep Course Presented at CANNT 2009
  • CEU Tests
  • ABSTRACTS 101 - Workshop Materials
• Resources
  • Career Opportunities (Last posting: August 9, 2010)
    • Advertisers
  • CANNT Awards, Bursaries & Grants
    • CANNT Bursaries & Grants
    • Excellence in Practice Awards
  • Amgen Canada Travel, Research & Preceptorship/Mentorship Grants Program
    • Grant Review Committee Assessment Guide
  • Internet Links
• Members
  • Renew Membership
  • CKD Review Modules
  • Change Password
  • Change Contact Info
  • Discussion Forum
  • CEU Tests
  • Purchase Tokens
  • Regional Reports
    • Western Region
    • Ontario
    • Quebec
    • Atlantic
    • Technical
  • Award Winners
  • Educational Opportunities
  • Refined Clinical Practice Groups (RCPGs)
    • RALNO
    • CHAC
  • My Profile

19_4_2

After reading the article, the reader will be able to:

1. Describe the pathophysiology and etiology of calciphylaxis.

2. Recognize patients at risk for calciphylaxis.

3. Discuss the utilization of sodium thiosulfate, bisphosphonates and cinacalcet (Sensipar®) for the treatment of calciphylaxis including evidence for efficacy and toxicity.